The combined net Q1 2024 revenue of approximately $2.4 million for prescription and non-prescription products increased approximately 20% versus net…
CARLSBAD, Calif., May 13, 2024 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today…
– Reports YCANTH® revenue of $3.2M for first quarter of 2024 – – Over 228 million lives now covered to date…
This marks the fourth consecutive year that Castle has earned a MedTech Breakthrough Award for its innovative testing solutionsFRIENDSWOOD, Texas--(BUSINESS…
Eversense® CGM+RPM solution to be powered by Rimidi’s clinical management platformGERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE American: SENS), a medical…
Revenue growth of 31% driven by strong clinical and biopharma volume and Guardant360 ASP tailwindsPALO ALTO, Calif.--(BUSINESS WIRE)--Guardant Health, Inc.…
NEW YORK--(BUSINESS WIRE)--Vim, a leading middleware platform for clinical workflow integration, and Pearl Health, a leading technology company focused on…
Total Revenue increased 28% and Procedure volume increased 25% over the first quarter of 2023 Increased ALLY® Adaptive Cataract Treatment…